trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Atherosclerosis D050197 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Alzheimer Disease D000544 76 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Melanoma D008545 69 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Neuroblastoma D009447 66 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Reperfusion Injury D015427 65 associated lipids
Nerve Degeneration D009410 53 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Asthma D001249 52 associated lipids
Osteosarcoma D012516 50 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Stroke D020521 32 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Cardiomegaly D006332 31 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Endometriosis D004715 29 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Glioblastoma D005909 27 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Nasal Polyps D009298 26 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Breast Neoplasms D001943 24 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Ailenberg M and Silverman M Trichostatin A-histone deacetylase inhibitor with clinical therapeutic potential-is also a selective and potent inhibitor of gelatinase A expression. 2002 Biochem. Biophys. Res. Commun. pmid:12379227
Remiszewski SW et al. Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates. 2002 J. Med. Chem. pmid:11831887
Kiefer SM et al. Murine Sall1 represses transcription by recruiting a histone deacetylase complex. 2002 J. Biol. Chem. pmid:11836251
Maecker HL et al. Epigenetic changes in tumor Fas levels determine immune escape and response to therapy. 2002 Cancer Cell pmid:12204534
Bharadwaj S and Prasad GL Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells. 2002 Cancer Lett. pmid:12065096
Sourlingas TG et al. The effect of the histone deacetylase inhibitor, trichostatin A, on total histone synthesis, H1(0) synthesis and histone H4 acetylation in peripheral blood lymphocytes increases as a function of increasing age: a model study. 2002 Jan-Mar Exp. Gerontol. pmid:11772521
Iwata K et al. Trichostatin A, a histone deacetylase inhibitor, down-regulates interleukin-12 transcription in SV-40-transformed lung epithelial cells. 2002 Jul-Aug Cell. Immunol. pmid:12470611
Noss KR et al. Methylation state of the prostate specific membrane antigen (PSMA) CpG island in prostate cancer cell lines. 2002 May-Jun Anticancer Res. pmid:12168830
Rahman I et al. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. 2002 May-Jun Mol. Cell. Biochem. pmid:12162440
Sakai N et al. Involvement of histone acetylation in ovarian steroid-induced decidualization of human endometrial stromal cells. 2003 J. Biol. Chem. pmid:12609987
Kim SY et al. Glial cell-specific regulation of the JC virus early promoter by histone deacetylase inhibitors. 2003 J. Virol. pmid:12610114
Wang S and Zhu J Evidence for a relief of repression mechanism for activation of the human telomerase reverse transcriptase promoter. 2003 J. Biol. Chem. pmid:12611896
Shaker S et al. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells. 2003 Leuk. Res. pmid:12620295
Dogra SC et al. Evidence that the coactivator CBP/p300 is important for phenobarbital-induced but not basal expression of the CYP2H1 gene. 2003 Mol. Pharmacol. pmid:12488538
James SY et al. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells. 2003 Cancer Res. pmid:12839938
McGhee L et al. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. 2003 J. Cell. Biochem. pmid:12874834
Chun AC and Jin DY Transcriptional regulation of mitotic checkpoint gene MAD1 by p53. 2003 J. Biol. Chem. pmid:12876282
Grisolano JL et al. An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12881486
Konduri SD et al. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. 2003 Oncogene pmid:12881707
Nakajima M et al. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells. 2003 Toxicol. Lett. pmid:12927368
Papeleu P et al. Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes. 2003 J. Hepatol. pmid:12927923
Hejnar J et al. Demethylation of host-cell DNA at the site of avian retrovirus integration. 2003 Biochem. Biophys. Res. Commun. pmid:14623319
Margueron R et al. Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells. 2003 J. Endocrinol. pmid:14529564
Agoulnik IU et al. Repressors of androgen and progesterone receptor action. 2003 J. Biol. Chem. pmid:12771131
Huang Y et al. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. 2003 Int. J. Cancer pmid:12640681
Vasudevan A et al. Heterocyclic ketones as inhibitors of histone deacetylase. 2003 Bioorg. Med. Chem. Lett. pmid:14592473
Chung YL et al. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. 2003 Mol. Ther. pmid:14599803
Lu F et al. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. 2003 J. Virol. pmid:14557628
Siddiqui H et al. Histone deacetylation of RB-responsive promoters: requisite for specific gene repression but dispensable for cell cycle inhibition. 2003 Mol. Cell. Biol. pmid:14560017
Martin D et al. Critical role of the transcriptional repressor neuron-restrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines. 2003 J. Biol. Chem. pmid:14565956
Wong JE et al. Therapeutic strategies in gastric cancer. 2003 J. Clin. Oncol. pmid:14645406
Suzuki M et al. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. 2003 Oncogene pmid:14647463
Yamada Y et al. Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer. 2003 Cancer Sci. pmid:12824880
Shi W et al. Induction of a senescent-like phenotype does not confer the ability of bovine immortal cells to support the development of nuclear transfer embryos. 2003 Biol. Reprod. pmid:12646489
Murumägi A et al. Characterization of regulatory elements and methylation pattern of the autoimmune regulator (AIRE) promoter. 2003 J. Biol. Chem. pmid:12651856
Kang J et al. Nickel-induced histone hypoacetylation: the role of reactive oxygen species. 2003 Toxicol. Sci. pmid:12773760
Maatouk DM and Resnick JL Continuing primordial germ cell differentiation in the mouse embryo is a cell-intrinsic program sensitive to DNA methylation. 2003 Dev. Biol. pmid:12781693
Ju R and Muller MT Histone deacetylase inhibitors activate p21(WAF1) expression via ATM. 2003 Cancer Res. pmid:12782595
Chua YL et al. The transcriptional enhancer of the pea plastocyanin gene associates with the nuclear matrix and regulates gene expression through histone acetylation. 2003 Plant Cell pmid:12782737
Cecconi D et al. Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A. 2003 Electrophoresis pmid:12783462
Fukuoka M et al. Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. 2003 Int. J. Mol. Med. pmid:12964026
Kao GD et al. Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response. 2003 J. Cell Biol. pmid:12668657
Yasui W et al. Histone acetylation and gastrointestinal carcinogenesis. 2003 Ann. N. Y. Acad. Sci. pmid:12724227
Jedrusik MA and Schulze E Telomeric position effect variegation in Saccharomyces cerevisiae by Caenorhabditis elegans linker histones suggests a mechanistic connection between germ line and telomeric silencing. 2003 Mol. Cell. Biol. pmid:12724425
Vos MD et al. The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. 2003 J. Biol. Chem. pmid:12676952
Detich N et al. The methyl donor S-Adenosylmethionine inhibits active demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-Adenosylmethionine. 2003 J. Biol. Chem. pmid:12676953
Foubister V Anticancer drug shows promise against lupus. 2003 Drug Discov. Today pmid:12681930
Park WH et al. Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis. 2003 Int. J. Oncol. pmid:12684681
Farhan H et al. Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells. 2003 J. Steroid Biochem. Mol. Biol. pmid:12732287
Chambers AE et al. Histone acetylation-mediated regulation of genes in leukaemic cells. 2003 Eur. J. Cancer pmid:12736119